ATE460937T1 - Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung - Google Patents

Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung

Info

Publication number
ATE460937T1
ATE460937T1 AT06751506T AT06751506T ATE460937T1 AT E460937 T1 ATE460937 T1 AT E460937T1 AT 06751506 T AT06751506 T AT 06751506T AT 06751506 T AT06751506 T AT 06751506T AT E460937 T1 ATE460937 T1 AT E460937T1
Authority
AT
Austria
Prior art keywords
production
methods
micronized tanaproget
tanaproget compositions
compositions
Prior art date
Application number
AT06751506T
Other languages
English (en)
Inventor
Arwinder Nagi
Ramarao Chatlapalli
Shamim Hasan
Mohamed Ghorab
Dhaval Gaglani
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE460937T1 publication Critical patent/ATE460937T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT06751506T 2005-04-28 2006-04-26 Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung ATE460937T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67555005P 2005-04-28 2005-04-28
PCT/US2006/015837 WO2006116514A2 (en) 2005-04-28 2006-04-26 Micronized tanaproget, compositions, and methods of preparing the same

Publications (1)

Publication Number Publication Date
ATE460937T1 true ATE460937T1 (de) 2010-04-15

Family

ID=37023145

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06751506T ATE460937T1 (de) 2005-04-28 2006-04-26 Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung

Country Status (19)

Country Link
US (4) US7767668B2 (de)
EP (1) EP1896034B8 (de)
JP (2) JP5149159B2 (de)
CN (1) CN101166532B (de)
AR (1) AR056328A1 (de)
AT (1) ATE460937T1 (de)
AU (1) AU2006241113B2 (de)
BR (1) BRPI0610437A2 (de)
CA (1) CA2603806C (de)
CY (1) CY1110009T1 (de)
DE (1) DE602006012972D1 (de)
DK (1) DK1896034T3 (de)
ES (1) ES2340610T3 (de)
MX (1) MX2007013465A (de)
PL (1) PL1896034T3 (de)
PT (1) PT1896034E (de)
SI (1) SI1896034T1 (de)
TW (1) TW200716129A (de)
WO (1) WO2006116514A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ556673A (en) 2005-02-03 2010-03-26 Gen Hospital Corp Method for treating gefitinib and/or erlotinib resistant cancer with an EGFR inhibitor
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
US7767668B2 (en) * 2005-04-28 2010-08-03 Wyeth Llc Micronized tanaproget, compositions, and methods of preparing the same
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
MX2007015571A (es) 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.
EP3488866A1 (de) 2005-11-04 2019-05-29 Wyeth LLC Antineoplastische kombinationen mit mtor-inhibitor, herceptin und/oder hki-272
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
US9040825B2 (en) * 2007-11-13 2015-05-26 Southwire Company, Llc Conductors and metal-covered cable with coded information and method of applying coded information
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
ES2531322T3 (es) 2008-06-17 2015-03-13 Wyeth Llc Combinaciones antineoplásicas que contienen HKI-272 y vinorelbina
EP3175853B1 (de) 2008-08-04 2023-11-01 Wyeth LLC Antineoplastische kombinationen aus neratinib und capecitabin
PT3000467T (pt) 2009-04-06 2023-03-30 Wyeth Llc Regime de tratamento utilizando neratinib para o cancro de mama
EP2498751B1 (de) 2009-11-09 2019-04-03 Wyeth LLC Umhüllte wirkstoffspäroide und verwendung davon zur verhinderung oder reduzierung von erbrechen und diarrhöe
EP3566697B1 (de) 2009-11-09 2024-09-11 Wyeth LLC Tablettenformulierungen aus neratinib-maleat
EP2512455B8 (de) 2009-12-18 2014-07-23 FrieslandCampina Nederland Holding B.V. Co-verarbeitete tablettenunterstützungszusammensetzung sowie ihre herstellung und verwendung
US9326997B2 (en) 2012-09-24 2016-05-03 Ahlam E. Elakkad Composition and method for treation Oligoovulation, Oligomenorrhea and Amenorrhea
AU2014268779A1 (en) 2013-05-21 2016-01-21 Predictive Therapeutics, LLC Therapeutic and method of use
GB201318394D0 (en) * 2013-10-17 2013-12-04 Univ Edinburgh Composition
WO2023025672A1 (en) 2021-08-25 2023-03-02 Basf Se Direct tableting auxiliary composition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
EP1531824A4 (de) * 2002-06-25 2005-09-21 Wyeth Corp Cyclothiocarbamat-derivate als pr-modulatoren und ihre verwendung bei der behandlung von hauterkrankungen
AU2003247608A1 (en) * 2002-06-25 2004-01-06 Wyeth Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
PA8631101A1 (es) 2004-04-27 2006-09-08 Wyeth Corp Proceso de acoplamiento para la generacion de derivados reactivos de pirrol-2-carbonitrilo n-sustituidos con contenido de boro para producir biarilos
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
GT200500183A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
AU2005272854B2 (en) * 2004-08-13 2012-04-26 Wyeth Tanaproget derivatives, metabolites, and uses thereof
CN101027321A (zh) * 2004-08-20 2007-08-29 惠氏公司 孕酮受体结构
ES2431324T3 (es) * 2005-04-28 2013-11-26 Wyeth Llc Forma purificada de tanaproget
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
US7767668B2 (en) 2005-04-28 2010-08-03 Wyeth Llc Micronized tanaproget, compositions, and methods of preparing the same
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Also Published As

Publication number Publication date
US8450312B2 (en) 2013-05-28
US7767668B2 (en) 2010-08-03
US8772271B2 (en) 2014-07-08
MX2007013465A (es) 2008-01-21
JP5149159B2 (ja) 2013-02-20
CN101166532A (zh) 2008-04-23
WO2006116514A2 (en) 2006-11-02
ES2340610T3 (es) 2010-06-07
JP2008539256A (ja) 2008-11-13
SI1896034T1 (sl) 2010-07-30
US20060246135A1 (en) 2006-11-02
AU2006241113B2 (en) 2011-08-18
AR056328A1 (es) 2007-10-03
US20100189789A1 (en) 2010-07-29
PL1896034T3 (pl) 2010-07-30
TW200716129A (en) 2007-05-01
CY1110009T1 (el) 2015-01-14
EP1896034B8 (de) 2010-05-19
WO2006116514A3 (en) 2006-12-14
JP2013006840A (ja) 2013-01-10
EP1896034A2 (de) 2008-03-12
CN101166532B (zh) 2011-06-22
BRPI0610437A2 (pt) 2012-10-23
CA2603806A1 (en) 2006-11-02
EP1896034B1 (de) 2010-03-17
US20140328925A1 (en) 2014-11-06
US20130251807A1 (en) 2013-09-26
DK1896034T3 (da) 2010-05-17
PT1896034E (pt) 2010-05-06
DE602006012972D1 (de) 2010-04-29
AU2006241113A1 (en) 2006-11-02
CA2603806C (en) 2013-03-19

Similar Documents

Publication Publication Date Title
EP2247196A4 (de) Süssmittelzusammensetzungen und verfahren zu ihrer herstellung
DE602006012972D1 (de) Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung
DE602006012283D1 (de) Integrierte schaltung und verfahren zu ihrer herstellung
DE602006020386D1 (de) Duraimplantat und Verfahren zu seiner Herstellung
DE602006001876D1 (de) Zementmischung und Verfahren zu ihrer Herstellung
ATE554772T1 (de) Pteridine als hcv-hemmer und verfahren zu ihrer herstellung
DE602005007419D1 (de) Rohmix-pulverzusammensetzungen und verfahren zu deren herstellung
EP1921674A4 (de) Halbleiterbauelement und verfahren zu seiner herstellung
EP2037433A4 (de) Display und prozess zu seiner herstellung
DE602006006654D1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
EP4183412C0 (de) Rsv-f-proteinzusammensetzungen und verfahren zu ihrer herstellung
DE602006004379D1 (de) Nanodraht-Struktur und Verfahren zu ihrer Herstellung
EP1994141A4 (de) Zusammensetzungen und verfahren zur kultivierung differenzierbarer zellen
ATE423166T1 (de) Pflanzliches-öl-stärkepfropfcopolymere und ihre biofaserverbundwerkstoffe und verfahren zu ihrer herstellung
EP1876398A4 (de) Verzweigte kühlmittelrelaiseinheit und verfahren zu ihrer herstellung
EP1906468A4 (de) Batteriedose und verfahren zu ihrer herstellung
EP2069467A4 (de) Trennungszusammensetzungen und verfahren zu ihrer verwendung
ZA200803891B (en) Colourant compositions
DE502006005961D1 (de) Endoskop und Verfahren zu seiner Herstellung
ATE460401T1 (de) 1,2,4,5-tetrahydro-3h-benzazepinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DK3330339T3 (da) Sammensætninger omfattende hfc-1234ze
IL184834A0 (en) Compositions and methods for the manufacture thereof
DE602006014621D1 (de) Antimikrobielles Nahtmaterial und Verfahren zu seiner Herstellung
DE112006002769A5 (de) Bodenverbesserungsmittel und Verfahren zu dessen Herstellung
ATE461266T1 (de) Zusammensetzung mit verbesserter stabilität und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1896034

Country of ref document: EP